Eccogene gets $60M from AstraZeneca; Evotec also records milestone with BMS

Plus, news about DBV, Double Point Ventures and Lumos:

Eccogene’s $60M milestone from AstraZeneca: The payment arrived after Eccogene met several …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Olympian’s Eye Condition Explained; BRAT Summer Diet; Can Patients Predict Death?

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. As the Summer Olympic Games kicked off in Paris, a

August 2, 2024

Galera considers ‘strategic’ options; Novo partners with French biotech; AnHeart gets $40M

Plus, news about Imagine Pharma. Galera to seek ‘strategic alternatives’ after FDA rejection: The company said Tuesday that the FDA asked for another Phase III

November 1, 2023

FDA says four doses of Lilly’s diabetes drug Mounjaro will be in short supply through April

The FDA said Tuesday that shortages of three higher doses of Eli Lilly’s type 2 diabetes drug Mounjaro aren’t expected to ease until May, and

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.